Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Targeted Genetics preclinical data

In a mouse model of human ovarian cancer, the combination of tgDCC-E1A plus paclitaxel and cisplatin

Read the full 160 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE